NEWS & AWARDS
ALL SYNAPSY'S NEWS
SEARCH SYNAPSY’S NEWS
JUMP TO A SPECIFIC MONTH
From academia to entrepreneurship – seizing an opportunity to make a significant contribution to the treatment of neurological disorders
17 December 2020
We spoke with Charles Finsterwald, PhD, Chief Scientific Officer and co-founder of the start-up Gliapharm about his career path and his decision to switch from fundamental research to application.An interest...
Read More
Lactate, a prospect for the treatment of depression
17 December 2020
According to WHO, more than 264 million people in the world suffer from depression, a disorder that has a major impact on all facets of the lives of those it...
Read More
Holography and cellular reprogramming in the quest for biomarkers
17 December 2020
Bipolar disorders affect some 2% of the population. Patients present a wide variety of clinical symptoms of which many can be especially handicapping. A new approach to find biomarkers, driven...
Read More
A career at the intersection of physics and psychiatry
17 December 2020
Pierre Marquet’s career path has been rather untypical. Combining qualifications in physics and psychiatry-psychotherapy, he is a clinical researcher “par excellence”, engaged for over 20 years in the development of...
Read More
From science to yoga — and back to science
17 December 2020
After initial studies in science, Zeynep Knight-Celen opts for a life practicing and teaching yoga. Ten years later her interest in the workings of the mind rekindles her scientific curiosity...
Read More
A psychologist in a clinical research team
17 December 2020
Ryan Murray’s work within Synapsy WP#5 focuses on measuring brain reactivity to and recovery from psychosocial stress within clinical patients and healthy controls. He talked to us about his role...
Read More
Genetics to stratify the WP#5 cohort
17 December 2020
Giorgio Pistis is profiling polygenic scores to understand whether genetic risks associated with particular pathophysiological pathways are higher in specific sub-groups of patients of the mood disorder cohort. Synapsy met...
Read More
Editorial – by Camilla Bellone
17 December 2020
2020 has been a challenging year for the Synapsy community and for the whole society. The impact of the COVID-19 pandemic on health, economy and employment has been unprecedented worldwide....
Read More
Zoom Conference on Equal opportunity with Prof. Dr. Tom Welton
8 October 2020
A open conference organized by NCCR Molecular Systems with Prof. Dr. Tom Welton on the topic "Scientific Excellence and Equality – a Contradiction?" will take place November 4th, 13:30-15:10 on...
Read More
Johannes Gräff promoted to associate professor
1 October 2020
Prof. Johannes Gräff, Synapsy principal investigator, has been promoted to Associate Professor of Life Sciences at the School of Life Sciences at EPFL. At its meeting of 23/24 September 2020...
Read More
Obsessive Compulsive Disorders: How to treat OCD?
7 September 2020
The fourth most common psychiatric illness, OCD affects between 2 and 3% of the population. Obsessive compulsive disorder, called OCD, is a psychological disorder. It is characterized by distressing obsessions...
Read More
Editorial by Camilla Bellone, Carmen Sandi and Philippe Conus
19 August 2020
Dear Colleagues, It is with a profound grief that we are writing the editorial of this issue of the NCCR Synapsy Newsletter. As you certainly all know, Alexandre Dayer, the...
Read More
Synapsy model imitated worldwide
19 August 2020
The translational graduate program at the International Max-Planck Research School for Translational Psychiatry – which is similar to Synapsy’s – is used to teach physicians and researchers. Two PhD students...
Read More
Using genetics and sharing to study autism
19 August 2020
French researcher Thomas Bourgeron is a pioneer in genetic research on autism. The professor was also our guest at the last Neurobiology of Mental Health conference. In this article, he...
Read More
What will the psychiatry of tomorrow look like?
19 August 2020
A female student in medicine at the University of Geneva (who is keen to remain anonymous) dreams of a career in psychiatry. To achieve her goals, she is soaking up...
Read More
Confined planet: a challenge for women
14 July 2020
Following the WHO's announcement on the coronavirus pandemic, our planet entered several weeks of confinement. Since then, the scientific community has been studying the consequences of this health crisis, particularly...
Read More
Death of Prof. Alexandre Dayer, NCCR Synapsy director
30 June 2020
Dear members of the Synapsy community, It is with great sadness that I have to inform you of the tragic passing of our NCCR Synapsy Director, colleague and friend Alexandre....
Read More
Gliapharm completes a CHF 2 Million financing to advance its drug development program
28 May 2020
GliaPharm SA has completed a CHF 2 million financing. The company is initially focusing on an orphan neurological disease caused by a deficiency in brain metabolism that affects more than...
Read More
Optimus Agora Prize for Carmen Sandi and Dominique de Quervain
22 May 2020
Dominique de Quervain and Carmen Sandi are being awarded Optimus Agora Prize. Their project “Stress” encourages interaction with the public. Stress is part of everyday life. Better understanding it, and...
Read More
covidout.ch: maintaining mental health and developing coping skills
29 April 2020
The objective of this new web app, designed by caregivers and researchers, is to help people with temporary/reactional or chronic psychological suffering to find coping strategies to better cope with...
Read More
